It has been reported that p53 mutant lung cancer patients exhibited increased expression of immune checkpoint regulators, enhanced CD8 T cell infiltration and increased expression of effector T cell and interferon-γ associated genes [194]. This evidence concerns the gene TP53 and lung cancer.